{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:55:53Z","timestamp":1785610553896,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Science and Technology Major Project of China during the 13th Five-Year Plan Period","award":["2018ZX10302104"],"award-info":[{"award-number":["2018ZX10302104"]}]},{"name":"Liuzhou Key Laboratory of Severe Abdominal Infection Research\/Guangxi Key Laboratory of Clinical Disease Biotechnology Research","award":["LRYFQ202501"],"award-info":[{"award-number":["LRYFQ202501"]}]},{"name":"The Chinese Preventive Medicine Association's Hospital Infection Control Branch's Young Talent Support Program","award":["CPMA-HAIC-2024012900113"],"award-info":[{"award-number":["CPMA-HAIC-2024012900113"]}]},{"name":"the Science and Technology Project of Liuzhou","award":["2022SB009"],"award-info":[{"award-number":["2022SB009"]}]},{"name":"The Scientific Research Project of Liuzhou People's Hospital affiliated to Guangxi Medical University","award":["Lry202327"],"award-info":[{"award-number":["Lry202327"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82260124\u300181960115"],"award-info":[{"award-number":["82260124\u300181960115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The existing predictive models for talaromycosis in people living with HIV without skin lesions are limited by established risk factors and traditional statistical approaches. This study aims to develop an interpretable machine learning(ML) model for predicting the presence of talaromycosis in HIV patients without skin lesions and to validate its clinical applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective multicenter study involved the analysis of electronic medical records from four tertiary hospitals in China, covering the period from 2010 to 2019. The training dataset comprised 1009 HIV patients with opportunistic infections, while external validation was conducted using data from 305 patients at an independent center. From an initial set of 36 variables, twelve key features were selected, including albumin, absolute lymphocyte count, hemoglobin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), AST\/ALT ratio, C-reactive protein, white blood cell count, platelet count, peripheral or abdominal lymphadenopathy, CD4\n                      <jats:sup>+<\/jats:sup>\n                      T-cell count, and age. Five ML algorithms were evaluated using tenfold cross-validation. Model performance was measured using the AUC, ACC, and F1-score. Calibration curves and decision curve analysis (DCA) were employed to assess the model\u2019s reliability and clinical net benefit. The optimal model was subsequently implemented as a web-based tool.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The Support Vector Machine (SVM) exhibited superior performance compared to other models, achieving an AUC of 0.809 (95% CI 0.778\u20130.838), an ACC of 0.714, and an F1-score of 0.689. External validation demonstrated enhanced performance metrics, with an AUC of 0.921 (95% CI 0.889\u20130.951), ACC of 0.853, and an F1-score of 0.819. DCA indicated a significant net clinical benefit across various risk thresholds, and calibration curves showed strong concordance between predicted and observed risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The interpretable SVM model effectively stratifies the risk of talaromycosis in people living with HIV without skin lesions in endemic regions, aligning with WHO recommendations for early diagnosis and treatment of priority fungal pathogens. Its integration into a web-based tool enhances clinical accessibility for early intervention in resource-constrained settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11046-026-01089-y","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:59:14Z","timestamp":1784602754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Interpretable Machine Learning Model for Predicting the Presence of Talaromycosis in HIV Patients Lacking Skin Lesions"],"prefix":"10.1007","volume":"191","author":[{"given":"Jiaguang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhuai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongsheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"1","key":"1089_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12879-020-05260-8","volume":"20","author":"Y Qin","year":"2020","unstructured":"Qin Y, Huang X, Chen H, et al. Burden of Talaromyces marneffei infection in people living with HIV\/AIDS in Asia during the ART era: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):551. https:\/\/doi.org\/10.1186\/s12879-020-05260-8.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1089_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11046-019-00410-2","volume":"184","author":"C Cao","year":"2019","unstructured":"Cao C, Xi L, Chaturvedi V. Talaromycosis (penicilliosis) due to Talaromyces (Penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen. Mycopathologia. 2019;184(6):709\u201320. https:\/\/doi.org\/10.1007\/s11046-019-00410-2.","journal-title":"Mycopathologia"},{"issue":"1","key":"1089_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1742-6405-9-24","volume":"9","author":"M Larsson","year":"2012","unstructured":"Larsson M, Nguyen LHT, Wertheim HFL, et al. Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam. AIDS Res Ther. 2012;9(1):24.","journal-title":"AIDS Res Ther"},{"issue":"6","key":"1089_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10096-017-2927-6","volume":"36","author":"M Chayakulkeeree","year":"2017","unstructured":"Chayakulkeeree M, Denning DW. Serious fungal infections in Thailand. Eur J Clin Microbiol Infect Dis. 2017;36(6):931\u20135. https:\/\/doi.org\/10.1007\/s10096-017-2927-6.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"1089_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cmi.2018.04.018","volume":"25","author":"J Jiang","year":"2019","unstructured":"Jiang J, Meng S, Huang S, et al. Effects of Talaromyces marneffei infection on mortality of HIV\/AIDS patients in southern China: a retrospective cohort study. Clin Microbiol Infect. 2019;25(2):233\u201341. https:\/\/doi.org\/10.1016\/j.cmi.2018.04.018.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"1089_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/hiv.13024","volume":"21","author":"RS Ying","year":"2011","unstructured":"Ying RS, Le T, Cai WP, et al. Clinical epidemiology and outcome of HIV\u2010associated talaromycosis in Guangdong, China, during 2011\u20132017. HIV Med. 2011;21(11):729\u201338. https:\/\/doi.org\/10.1111\/hiv.13024.","journal-title":"HIV Med"},{"issue":"1-2","key":"1089_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11046-012-9577-0","volume":"175","author":"Y Hu","year":"2012","unstructured":"Hu Y, Zhang J, Li X, et al. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia. 2012;175(1\u20132):57\u201367. https:\/\/doi.org\/10.1007\/s11046-012-9577-0.","journal-title":"Mycopathologia"},{"issue":"6","key":"1089_CR8","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.4269\/ajtmh.16-0521","volume":"96","author":"J Chen","year":"2017","unstructured":"Chen J, Zhang R, Shen Y, et al. Clinical characteristics and prognosis of penicilliosis among human immunodeficiency virus-infected patients in Eastern China. Am J Trop Med Hyg. 2017;96(6):1350\u20134. https:\/\/doi.org\/10.4269\/ajtmh.16-0521.","journal-title":"Am J Trop Med Hyg"},{"issue":"11-12","key":"1089_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.medmal.2014.09.008","volume":"44","author":"VT Son","year":"2014","unstructured":"Son VT, Khue PM, Strobel M. Penicilliosis and AIDS in Haiphong, Vietnam: evolution and predictive factors of death. Med Mal Infect. 2014;44(11\u201312):495\u2013501. https:\/\/doi.org\/10.1016\/j.medmal.2014.09.008.","journal-title":"Med Mal Infect"},{"issue":"4","key":"1089_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/jinf.2002.1062","volume":"45","author":"KH Ranjana","year":"2002","unstructured":"Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur State, India. J Infect. 2002;45(4):268\u201371. https:\/\/doi.org\/10.1053\/jinf.2002.1062.","journal-title":"J Infect"},{"key":"1089_CR11","doi-asserted-by":"publisher","first-page":"656194","DOI":"10.3389\/fmed.2021.656194","volume":"8","author":"J Shi","year":"2021","unstructured":"Shi J, Yang N, Qian G. Case report: metagenomic next-generation sequencing in diagnosis of talaromycosis of an immunocompetent patient. Front Med (Lausanne). 2021;8:656194. https:\/\/doi.org\/10.3389\/fmed.2021.656194.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1089_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/CMR.19.1.95-110.2006","volume":"19","author":"N Vanittanakom","year":"2006","unstructured":"Vanittanakom N, Cooper CR, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95\u2013110. https:\/\/doi.org\/10.1128\/CMR.19.1.95-110.2006.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1089_CR13","doi-asserted-by":"publisher","first-page":"e0195569","DOI":"10.1371\/journal.pone.0195569","volume":"13","author":"Z Ruan","year":"2018","unstructured":"Ruan Z, Ning C, Lai J, et al. Accuracy of rapid diagnosis of Talaromyces marneffei: A systematic review and meta-analysis. PLoS ONE. 2018;13(4):e0195569.","journal-title":"PLoS ONE"},{"issue":"1","key":"1089_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2334-13-464","volume":"10","author":"R Kawila","year":"2013","unstructured":"Kawila R, Chaiwarith R, Supparatpinyo K. Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: a retrospective study. AIDS Res Ther. 2013;10(1):12. https:\/\/doi.org\/10.1186\/1471-2334-13-464.","journal-title":"AIDS Res Ther"},{"key":"1089_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/764293","volume":"2011","author":"SYN Wong","year":"2011","unstructured":"Wong SYN, Wong KF. Penicillium marneffei infection in AIDS. Pathol Res Int. 2011;2011:1\u201310. https:\/\/doi.org\/10.4061\/2011\/764293.","journal-title":"Pathol Res Int"},{"issue":"1","key":"1089_CR16","first-page":"66","volume":"67","author":"NH Shaharuddin","year":"2012","unstructured":"Shaharuddin NH, Sahlawati M, Kumar CS, Christopher Lee KC. A retrospective review on successful management of Penicillium Marneffei infections in patients with advanced HIV. Med J Malaysia. 2012;67(1):66\u201370.","journal-title":"Med J Malaysia"},{"issue":"24","key":"1089_CR17","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1056\/NEJMoa1613306","volume":"376","author":"T Le","year":"2017","unstructured":"Le T, Kinh NV, Cuc NTK, et al. A trial of itraconazole or amphotericin B for HIV-associated talaromycosis. N Engl J Med. 2017;376(24):2329\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1613306.","journal-title":"N Engl J Med"},{"key":"1089_CR18","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268824001456","author":"X Li","year":"2024","unstructured":"Li X, Jiang Z, Mo S, et al. A web-based dynamic nomogram for estimating talaromycosis risk in hospitalized HIV-positive patients. Epidemiol Infect. 2024. https:\/\/doi.org\/10.1017\/S0950268824001456.","journal-title":"Epidemiol Infect"},{"key":"1089_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8661324","volume":"2022","author":"W Ren","year":"2022","unstructured":"Ren W, Li D, Wang J, et al. Prediction and evaluation of machine learning algorithm for prediction of blood transfusion during cesarean section and analysis of risk factors of hypothermia during anesthesia recovery. Comput Math Methods Med. 2022;2022:1\u20139. https:\/\/doi.org\/10.1155\/2022\/8661324.","journal-title":"Comput Math Methods Med"},{"issue":"6","key":"1089_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tig.2020.03.005","volume":"36","author":"CB Azodi","year":"2020","unstructured":"Azodi CB, Tang J, Shiu S-H. Opening the black box: interpretable machine learning for geneticists. Trends Genet. 2020;36(6):442\u201355. https:\/\/doi.org\/10.1016\/j.tig.2020.03.005.","journal-title":"Trends Genet"},{"key":"1089_CR21","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. https:\/\/doi.org\/10.1136\/bmj-2023-078378.","journal-title":"BMJ"},{"issue":"6","key":"1089_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, Mcculloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710\u20138. https:\/\/doi.org\/10.1093\/aje\/kwk052.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"1089_CR23","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1177\/0962280218784726","volume":"28","author":"M van Smeden","year":"2018","unstructured":"van Smeden M, Moons KGM, de Groot JAH, et al. Sample size for binary logistic prediction models: Beyond events per variable criteria. Stat Methods Med Res. 2018;28(8):2455\u201374. https:\/\/doi.org\/10.1177\/0962280218784726.","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"1089_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","volume":"1","author":"C Rudin","year":"2019","unstructured":"Rudin C. Stop explaining black-box machine learning models for high-stakes decisions and use interpretable models instead. Nat Mach Intell. 2019;1(5):206\u201315. https:\/\/doi.org\/10.1038\/s42256-019-0048-x.","journal-title":"Nat Mach Intell"},{"issue":"13","key":"1089_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMra2212850","volume":"389","author":"DJ Hunter","year":"2023","unstructured":"Hunter DJ, Drazen JM, Kohane IS, et al. Where medical statistics meets artificial intelligence. N Engl J Med. 2023;389(13):1211\u20139. https:\/\/doi.org\/10.1056\/NEJMra2212850.","journal-title":"N Engl J Med"},{"key":"1089_CR26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jconrel.2022.11.014","volume":"352","author":"R Ota","year":"2022","unstructured":"Ota R, Yamashita F. Application of machine learning techniques to the analysis and prediction of drug pharmacokinetics. J Control Release. 2022;352:961\u20139. https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.014.","journal-title":"J Control Release"},{"issue":"1","key":"1089_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/07853890.2022.2160008","volume":"55","author":"S-N Zhou","year":"2022","unstructured":"Zhou S-N, Da-Wei JV, Meng X-F, et al. Feasibility of machine learning-based modeling and prediction using multiple centers\u2019 data to assess intrahepatic cholangiocarcinoma outcomes. Annal Med. 2022;55(1):215\u201323.","journal-title":"Annal Med"},{"issue":"6429","key":"1089_CR28","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1126\/science.aaw0029","volume":"363","author":"RB Parikh","year":"2019","unstructured":"Parikh RB, Obermeyer Z, Navathe AS. Regulation of predictive analytics in medicine. Science. 2019;363(6429):810\u20132. https:\/\/doi.org\/10.1126\/science.aaw0029.","journal-title":"Science"},{"issue":"4","key":"1089_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/WCO.0000000000001081","volume":"35","author":"TL Adali","year":"2022","unstructured":"Adali TL, Calhoun VD. Reproducibility and replicability in neuroimaging data analysis. Curr Opin Neurol. 2022;35(4):475\u201381. https:\/\/doi.org\/10.1097\/WCO.0000000000001081.","journal-title":"Curr Opin Neurol"},{"key":"1089_CR30","unstructured":"WHO. WHO fungal priority pathogens list to guide research, development, and public health action. 2022. (accessed July 31, 2023)."},{"key":"1089_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-023-02253-w","author":"Y Shi","year":"2023","unstructured":"Shi Y, Zhang G, Ma C, et al. Machine learning algorithms to predict intraoperative hemorrhage in surgical patients: a modeling study of real-world data in Shanghai, China. BMC Med Inform Decis Mak. 2023. https:\/\/doi.org\/10.1186\/s12911-023-02253-w.","journal-title":"BMC Med Inform Decis Mak"},{"key":"1089_CR32","doi-asserted-by":"publisher","first-page":"102409","DOI":"10.1016\/j.eclinm.2023.102409","volume":"68","author":"J Hu","year":"2024","unstructured":"Hu J, Xu J, Li M, et al. Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study. EClinicalMedicine. 2024;68:102409. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102409.","journal-title":"EClinicalMedicine"},{"issue":"16","key":"1089_CR33","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.7150\/ijms.65040","volume":"18","author":"Y Yu","year":"2021","unstructured":"Yu Y, Lin J, Muto C, et al. Assessment of the utility of physiologically-based pharmacokinetic model for prediction of pharmacokinetics in Chinese and Japanese populations. Int J Med Sci. 2021;18(16):3718\u201327. https:\/\/doi.org\/10.7150\/ijms.65040.","journal-title":"Int J Med Sci"},{"issue":"7","key":"1089_CR34","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/1471-0528.17729","volume":"131","author":"SJ Kitson","year":"2023","unstructured":"Kitson SJ, Crosbie EJ, Evans DG, et al. Predicting risk of endometrial cancer in asymptomatic women (PRECISION): model development and external validation. BJOG. 2023;131(7):996\u20131005. https:\/\/doi.org\/10.1111\/1471-0528.17729.","journal-title":"BJOG"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01089-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-026-01089-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01089-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:02:36Z","timestamp":1785607356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-026-01089-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1007\/s11046-026-01089-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7442583\/v1","asserted-by":"object"}]},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"66"}}